Callan JMB Inc.
CJMB
NASDAQ·Industrials·Integrated Freight & Logistics·Mkt cap $10.1M
$2.11
▲ 0.00%
P/E
-1.50
Mkt Cap
$10.1M
52-Wk Range
$0.65–$5.61
52-Week Range
$0.65 - $5.61
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Down 56.6% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- Specialized expertise in ultra-cold chain logistics for regulated life sciences
- Established relationships with biotech and pharmaceutical companies
- Proprietary thermal management technology and packaging solutions
- Regulatory compliance and quality certifications in life sciences logistics
Bear Case
1 risk
- Low volatility (beta -0.7).
Growth
No forward estimates available
Surge in cell therapy and regenerative medicine commercialization
Value
Valuation data unavailable
Momentum
Hot
+175.1% over 3m
Quality
Stable
Below average quality
Dividend
None
No dividend
Smart-money signal
Who's buying CJMB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
AUG 14, 2026
Most recent quarter reported revenue of $1.4M (-17% YoY). Reported EPS of -$0.22. Gross margin 55.1%.
Reported EPS · last 4Q
0 of 1 beats
Q3 26
—
Revenue trend · last 8Q
—
—
-19%
-16%
+1%
-14%
-24%
-17%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$1.4M
$1.4M
$1.4M
$1.7M
$1.4M
$1.2M
$1.1M
$1.4M
Margins · last 8Q
Gross
55.1%
Operating
-97.8%
Profit
-89.5%
Wall Street consensus
Analyst coverage
Live ratings and price targets aggregated across covering analysts.
vs Industry
How CJMB stacks vs Integrated Freight & Logistics
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related